Ongoing clinical trials of lipid reduction therapy in patients with renal disease

Kidney International, Supplement

Volumn 56, Issue 71, 1999, Pages

  Yukawa, Susumu ^a   Mune, Masatoshi ^a   Yamada, Yoichi ^a   Otani, Haruhisa ^a   Kishino, Masanori ^a   Tone, Yoshinori ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Cardiovascular; Clinical trials; Dialysis; Hyperlipidemia; Progressive renal disease

Indexed keywords

ALPHA TOCOPHEROL; ANTILIPEMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOW DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

APHERESIS; CONFERENCE PAPER; DIALYSIS; HUMAN; HYPERLIPIDEMIA; KIDNEY DISEASE; LIPOPROTEIN METABOLISM; PRIORITY JOURNAL; PROTEINURIA; BLOOD; CLINICAL TRIAL; DRUG EFFECT; REVIEW;

ANTILIPEMIC AGENTS; BLOOD COMPONENT REMOVAL; CLINICAL TRIALS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KIDNEY DISEASES; LIPOPROTEINS, LDL;

EID: 0032973547     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. KEANE WF: Lipids and the kidney. Kidney Int 46:910-920, 1994
2. MASCHIO G, OLDRIZZI L, RUGIO C, DEBIASE V, LOSCHIAVO C: Effect of dietary manipulation on the lipid abnormalities in patients with chronic renal failure. Kidney Int 39(Suppl 31):S70-S72, 1991
3. SAMUELSSON O, MULEC H, KNIGHT-GIBSON C, ATTMAN P-O, KRON B, LARSSON R, WEISS L, WEDEL H, ALAUPOVIC P: Lipoprotein abnormalities are associated with increased rate of progression of human renal insufficiency. Nephrol Dial Transplant 12:1908-1915, 1997
4. SAMUELSSON O, AURELL M, KNIGHT-GIBSON C, ALAUPOVIC P, ATTMAN P-O: Apolipoprotein-B-containing lipoproteins and the progression of renal insufficiency. Nephron 63:279-285, 1993
5. SAMUELSSON O, ATTMAN P-O, KNIGHT-GIBSON C, LARSSON R, MULEC H, WEISS L, ALAUPOVIC P: Complex apolipoprotein B-containing lipoprotein particles are associated with a high rate of progression of human progressive renal insufficiency. J Am Soc Nephrol 9:1482-1488, 1998
6. MASSY ZA, MA JZ, Louis TA, KASISKE BL: Lipid-lowering therapy in patients with renal disease. Kidney Int 48:188-198, 1995
7. THOMAS ME, HARRIS KPG, RAMASWAMY C, HATTERLEY JM, WHEELER DC, VARGHESE Z, WILLIAMS JD, WALLIS J, MOORHEAD JF: Simvastatin therapy for hypercholesteromic patients with nephrotic syndrome or significant proteinuria. Kidney Int 44:1124-1129, 1993
8. MATOBA K, MUNE M, YAMADA Y, OHTANI H, NAKAHARA K, YUKAWA S, NOMOTO H: Lowering effect of probucol on proteinuria in hyperlipidemic patients with chronic nephrotic syndrome. Kidney Dial (Jpn) 31:1131-1135, 1991
9. NIELSEN S, SCHMITZ O, MÖLLER N, PÖRKSEN N, KLAUSEN IC, ALBERTI KGMM, MOGENSEN CE: Renal function and insulin sensitivity during simvastatin treatment in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 36:1019-1086, 1993
10. LONDON GM, DRÜEKE TB: Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney Int 51:1678-1695, 1997
11. YUKAWA S, HIBINO A, MAEDA T, MIMURA K, YUKAWA A, MAEDA A, KISHINO M, SONOBE M, MUNE M, YAMADA Y, NISHIDE I: Effect of alpha-tocopherol on in vitro and in vivo metabolism of low-density lipoproteins in hemodialysis patients. Nephrol Dial Transplant 10(Suppl 3):1-3, 1995
12. HAHN R, OETTE K, MONDORF H, FINKE K, SIEBERTH HG: Analysis of cardiovascular risk factors in chronic hemodialysis patients with special attention to the hyperlipoproteinemias. Atherosclerosis 48:279-288, 1983
13. NISHIZAWA Y, SHOJI T, NISHITANI H, YAMAKAWA M, KONISHI T, KAWASAKI K, MORII H: Hypertriglyceridemia and lowering apolipoprotein C-II/C-III ratio in uremia: Effect of a fibric acid, clinofibrate. Kidney Int 44:1352-1359, 1993
14. NISHIKAWA O, MAEDA A, TAKAHASHI T, KIMURA K, KISHINO M, TONE Y, OHTANI H, OGAWA A, MUNE M, MAEDA T, YUKAWA S: Effects of simvastatin on lipid profile of patients with chronic renal failure requiring hemodialysis. J Jpn Soc Dial Ther (Jpn) 28:987-994, 1995
15. YUKAWA S, SONOBE M, TONE Y, YUKAWA A, MIMURA K, MUNE M, MAEDA T, NOMOTO H, NISHIDE I: Prevention of aortic calcification in patients on hemodialysis by long-term administration of vitamin E, in Vitamins and Biofactors in Life Science, edited by Kobayashi T, Tokyo, Center for Academic Publications, 1992, pp 187-190
16. BEHRENS WA, THOMPSON JN, MADERE R: Distribution of alphatocopherol in human plasma lipoproteins. Am J Clin Nutr 35:691-696, 1982